UnitedHealth Group Incorporated (NYSE:UNH) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a note issued to investors on Thursday.

According to Zacks, “Shares of UnitedHealth Group outperformed the industry in past six months. Robust Government business and continued strong performance at Optum are driving the company’s long-term growth. International business and strong capital position are its other positives. It has been witnessing an increase in membership for the past many years. On the back of its impressive earnings in the first nine months, the company raised its 2017 guidance. It has reduced exposure to the troubled public exchange business. Though this move will shield it from losses in this business, premium revenues are likely to be affected. Charges related to Penn Treaty are other causes of concern.”

Several other analysts have also recently commented on the company. Cantor Fitzgerald reiterated an “overweight” rating and issued a $208.00 target price on shares of UnitedHealth Group in a report on Friday, July 21st. ValuEngine upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Friday, September 1st. Oppenheimer Holdings, Inc. reiterated an “outperform” rating and issued a $205.00 target price (up from $203.00) on shares of UnitedHealth Group in a report on Friday, July 21st. BidaskClub cut UnitedHealth Group from a “strong-buy” rating to a “buy” rating in a report on Wednesday, July 19th. Finally, Barclays PLC increased their price target on UnitedHealth Group from $200.00 to $217.00 and gave the stock an “overweight” rating in a report on Wednesday, July 19th. Three research analysts have rated the stock with a hold rating and twenty-four have assigned a buy rating to the company. The stock has a consensus rating of “Buy” and an average price target of $216.65.

Shares of UnitedHealth Group (NYSE:UNH) traded up $3.34 during midday trading on Thursday, reaching $212.87. The company’s stock had a trading volume of 2,196,909 shares, compared to its average volume of 3,520,000. UnitedHealth Group has a 12-month low of $136.22 and a 12-month high of $213.83. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.72 and a current ratio of 0.70. The firm has a market capitalization of $205.82 billion, a P/E ratio of 21.99, a price-to-earnings-growth ratio of 1.57 and a beta of 0.64.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.57 by $0.09. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The business had revenue of $50.32 billion for the quarter, compared to analysts’ expectations of $50.38 billion. During the same period in the prior year, the business posted $2.17 earnings per share. The firm’s revenue was up 8.7% on a year-over-year basis. equities research analysts forecast that UnitedHealth Group will post 9.99 EPS for the current year.

TRADEMARK VIOLATION WARNING: This story was originally posted by Watch List News and is the sole property of of Watch List News. If you are reading this story on another website, it was illegally copied and reposted in violation of US and international copyright and trademark laws. The original version of this story can be read at https://www.watchlistnews.com/unitedhealth-group-incorporated-unh-rating-lowered-to-hold-at-zacks-investment-research/1678889.html.

In other news, Director Gail R. Wilensky sold 5,600 shares of the firm’s stock in a transaction on Tuesday, September 5th. The stock was sold at an average price of $199.49, for a total transaction of $1,117,144.00. Following the completion of the sale, the director now directly owns 60,834 shares of the company’s stock, valued at approximately $12,135,774.66. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Richard T. Burke sold 15,000 shares of the firm’s stock in a transaction on Monday, August 21st. The shares were sold at an average price of $191.71, for a total value of $2,875,650.00. Following the sale, the director now directly owns 1,818,898 shares of the company’s stock, valued at $348,700,935.58. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 72,149 shares of company stock valued at $14,212,342. Insiders own 0.89% of the company’s stock.

Several institutional investors have recently made changes to their positions in the company. Regal Wealth Group Inc. increased its position in shares of UnitedHealth Group by 0.4% during the 2nd quarter. Regal Wealth Group Inc. now owns 746 shares of the healthcare conglomerate’s stock valued at $138,000 after purchasing an additional 3 shares during the last quarter. Jackson Grant Investment Advisers Inc. grew its stake in shares of UnitedHealth Group by 0.4% during the 2nd quarter. Jackson Grant Investment Advisers Inc. now owns 1,101 shares of the healthcare conglomerate’s stock worth $204,000 after acquiring an additional 4 shares during the period. RB Capital Management LLC grew its stake in shares of UnitedHealth Group by 0.4% during the 2nd quarter. RB Capital Management LLC now owns 1,732 shares of the healthcare conglomerate’s stock worth $321,000 after acquiring an additional 7 shares during the period. Altfest L J & Co. Inc. grew its stake in shares of UnitedHealth Group by 0.3% during the 2nd quarter. Altfest L J & Co. Inc. now owns 2,963 shares of the healthcare conglomerate’s stock worth $549,000 after acquiring an additional 10 shares during the period. Finally, Parkside Financial Bank & Trust grew its stake in shares of UnitedHealth Group by 1.4% during the 1st quarter. Parkside Financial Bank & Trust now owns 854 shares of the healthcare conglomerate’s stock worth $140,000 after acquiring an additional 12 shares during the period. 86.14% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.